Advertisement

Journal of Contemporary Psychotherapy

, Volume 44, Issue 1, pp 53–61 | Cite as

Chasing the Latest Fad: Confronting Recent and Historical Innovations in Mental Illness

  • James C. Overholser
Original Paper

Abstract

In recent years, there have been many innovative changes in the field of mental illness. The field has generated numerous creative ideas that help to expand our understanding of the diagnosis and treatment of mental illness. Unfortunately, some ideas are best viewed as passing fads that display a characteristic sudden rise in popularity, only to disappear after a brief period of fame and acclaim. The present manuscript confronts several recent and historical fads in the diagnosis and treatment of mental illness. Instead of seeking novel approaches, mental health professionals are best guided by common sense and modest skepticism.

Keywords

Psychiatry Medications Historical factors Novelty Innovation Fad 

Notes

Acknowledgments

The author thanks Julia DiFilippo, Jenny Lehmann, and Patti Watson for valuable feedback on earlier drafts of this paper.

References

  1. Abbey, S., & Garfinkel, P. (1991). Neurasthenia and chronic fatigue syndrome: The role of culture in the making of a diagnosis. American Journal of Psychiatry, 148(12), 1638–1646.PubMedGoogle Scholar
  2. Abse, W., Dahlstrom, W., & Tolley, A. (1960). Evaluation of tranquilizing drugs in the management of acute mental disturbance. American Journal of Psychiatry, 116, 973–980.PubMedGoogle Scholar
  3. Allen, C. (1937). Psychological factors in continuous bath hydrotherapy for psychotic patients. Journal of Abnormal and Social Psychology, 31(4), 418–422.Google Scholar
  4. Altschule, M., & Tillottson, K. (1948). The use of testosterone in the treatment of depressions. New England Journal of Medicine, 239, 1036–1038.PubMedGoogle Scholar
  5. Ambrosini, P., Bianchi, M., Rabinovich, H., & Elia, J. (1993). Antidepressant treatments in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 32(1), 1–6.PubMedGoogle Scholar
  6. American Psychiatric Association. (1968). Diagnostic and Statistical Manual of Mental Disorders. 2nd ed: DSM-II (Vol. 2). Washington, DC: American Psychiatric Publishing.Google Scholar
  7. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd ed: DSM-III. Washington, DC: American Psychiatric Publishing.Google Scholar
  8. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed: DSM-5. Washington, DC: American Psychiatric Publishing.Google Scholar
  9. Anderson, J. (1913). Some remarks on acute mania and its treatment. Australasian Medical Gazette, 34, 285–289.Google Scholar
  10. Azima, H. (1955). Prolonged sleep treatment in mental disorders. Journal of Mental Science, 101, 593–603.PubMedGoogle Scholar
  11. Baio, J. (2012). Prevalence of autism spectrum disorders. Morbidity and Mortality Weekly Report, 61(supp 3), 1–19.Google Scholar
  12. Barr, E., & Barry, R. (1926). The effect of producing aseptic meningitis upon dementia praecox. New York State Journal of Medicine, 26, 89–92.Google Scholar
  13. Beard, G. (1873). The treatment of insanity by electricity. Journal of Mental Science, 19, 355–360.Google Scholar
  14. Berlim, M., McGirr, A., Beaulieu, M., & Turecki, G. (2011). High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression. Journal of Affective Disorders, 130, 312–317.PubMedGoogle Scholar
  15. Bhatia, M. (2012). Over diagnosis, overshadowing, and overtreatment in psychiatry. Delhi Psychiatry Journal, 15(1), 3–4.Google Scholar
  16. Blake, J., & Hamilton, A. (1880). A preliminary report upon the use of dilute nitrous oxide gas in the treatment of melancholia and nervous exhaustion. Lancet, 17, 118.Google Scholar
  17. Bleckwenn, W. (1930). Narcosis as therapy in neuropsychiatric conditions. Journal of the American Medical Association, 95, 1168–1171.Google Scholar
  18. Burman, J. (1872). On conia and its use in subcutaneous injection. West Riding Lunatic Asylum Medical Reports, 2, 1–40.Google Scholar
  19. Byrne, S., & Rothschild, A. (1998). Loss of antidepressant efficacy during maintenance therapy. Journal of Clinical Psychiatry, 59, 279–288.PubMedGoogle Scholar
  20. Caplan, R. (1969). Psychiatry and the community in Nineteenth century America (chapter 26). New York: Basic Books.Google Scholar
  21. Carson, P., Lanier, P., Carson, K., & Birkenmeier, B. (1999). A historical perspective on fad adoption and abandonment. Journal of Management History, 5(6), 320–333.Google Scholar
  22. Chwalisz, K. (2003). Evidence-based practice. The Counseling Psychologist, 31(5), 497–528.Google Scholar
  23. Clapp, J., & Loomis, E. (1950). Continuous sleep treatment. American Journal of Psychiatry, 106, 821–829.PubMedGoogle Scholar
  24. Coo, H., Ouellette-Kuntz, H., Lloyd, J., Kasmara, L., Holden, J., & Lewis, M. (2008). Trends in autism prevalence: Diagnostic substitution revisited. Journal of Autism and Developmental Disorders, 38, 1036–1046.PubMedGoogle Scholar
  25. Courtenay, E. (1872). The use of opium in the treatment of melancholia. West Riding Lunatic Asylum Medical Reports, 2, 254–277.Google Scholar
  26. Danzinger, L. (1942). Estrogen therapy of agitated depressions associated with the menopause. Archives of Neurology and Psychiatry, 47, 305–313.Google Scholar
  27. Denber, H., & Merlis, S. (1954). A note on some therapeutic implications of the mescaline-induced state. Psychiatric Quarterly, 28, 635–640.Google Scholar
  28. DeWatteville, A. (1885). Practical remarks on the use of electricity in mental disease. Journal of Mental Science, 30, 483–488.Google Scholar
  29. Fitzgerald, P., Benitez, J., Daskalakis, J., Brown, T., Marston, N., Castella, A., et al. (2005). A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology, 25(4), 358–362.PubMedGoogle Scholar
  30. Frances, A. (2010). Normality is an endangered species. Psychiatric Times, 27(7).Google Scholar
  31. Frances, A., & Widiger, T. (2012). Psychiatric diagnosis: Lessons from the DSM-IV past and cautions for the DSM-5 future. Annual Review of Clinical Psychology, 8, 109–130.PubMedGoogle Scholar
  32. George, M., Sackheim, H., Marangell, L., Husain, M., Nahas, Z., Lisanby, S., et al. (2000a). Vagus nerve stimulation: A potential therapy for resistant depression. Psychiatric Clinics of North America, 23, 757–783.PubMedGoogle Scholar
  33. George, M., Sackheim, H., Rush, A., Marangell, L., Nahas, Z., et al. (2000b). Vagus nerve stimulation: A new tool for brain research and therapy. Biological Psychiatry, 47, 287–295.PubMedGoogle Scholar
  34. Georgotas, A., & McCue, R. (1989). Relapse of depressed patients after effective continuation therapy. Journal of Affective Disorders, 17, 159–164.PubMedGoogle Scholar
  35. Gilula, M., & Kirsch, D. (2005). Cranial electrotherapy stimulation review. Journal of Neurotherapy, 9(2), 7–26.Google Scholar
  36. Gregg, D. (1914). A comparison of the drugs used in general and mental hospitals. Boston Medical and Surgical Hospital, 171, 476–477.Google Scholar
  37. Guttmann, E. (1934). The effect of benzedrine on depressive states. Journal of Mental Science, 80, 618–620.Google Scholar
  38. Hauri, P. (1974). Sleep in depression. Psychiatric Annals, 4, 45–62.Google Scholar
  39. Haviland, C. (1902). Tent life for the tuberculous insane. American Journal of Insanity, 59, 319–327.Google Scholar
  40. Haviland, C., & Carlisle, C. (1905). Extension of tent therapy to additional classes of the insane. American Journal of Insanity, 62, 95–115.Google Scholar
  41. Haygarth, J. (1801/1963). Of the imagination as a cause and as a cure of disorders of the body. In R. Hunter & I. MacAlpine (Eds.), Three hundred years of psychiatry: 15351860 (Reprinted, pp. 573–575). New York: Oxford University Press. Google Scholar
  42. Heimann, C. (1887). Cocaine in the treatment of mental disorders. Journal of Mental Science, 33, 230–238.Google Scholar
  43. Heldt, T. (1947). The therapeutic use of prolonged sodium amytal narcosis. American Journal of Psychiatry, 104, 27–35.PubMedGoogle Scholar
  44. Hinsie, L. (1929). The treatment of schizophrenia. Psychiatric Quarterly, 3(1), 5–39.Google Scholar
  45. Hoch, P. (1935). Treatment of schizophrenia with prolonged narcosis. Psychiatric Quarterly, 9, 386–391.Google Scholar
  46. Holsboer-Trachsler, E., & Ernst, K. (1986). Sustained antidepressive effects of repeated partial sleep deprivation. Psychopathology, 19(suppl 2), 172–176.PubMedGoogle Scholar
  47. Kerbikov, O. (1955). Treatment of mental disease by sleep. Lancet, 1, 744–745.Google Scholar
  48. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1, 1–18.Google Scholar
  49. Kozel, F., George, M., & Simpson, K. (2004). Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectrum, 9(6), 476–482.Google Scholar
  50. Kuh, S. (1918). Melancholia. Journal of Nervous and Mental Disease, 47, 411–417.Google Scholar
  51. Kupfer, D. (1991). Long-term treatment of depression. Journal of Clinical Psychiatry, 52(Suppl 5), 28–34.PubMedGoogle Scholar
  52. Kupfer, D. (1992). Maintenance treatment in recurrent depression. British Journal of Psychiatry, 161, 309–316.PubMedGoogle Scholar
  53. Lehmann, H., & Bos, C. (1947). The advantages of nitrous oxide inhalation in psychiatric treatment. American Journal of Psychiatry, 104, 164–170.PubMedGoogle Scholar
  54. Leo, R., & Ligot, J. (2007). A systematic review of randomized controlled trials of acupuncture in the treatment of depression. Journal of Affective Disorders, 97, 13–22.PubMedGoogle Scholar
  55. Lilly, B., & Nelson, T. (2003). Fads: Segmenting the fad-buyer market. Journal of Consumer Marketing, 20(3), 252–265.Google Scholar
  56. Loo, C., Mitchell, P., Sachdev, P., McDarmont, B., Parker, G., & Gandevia, S. (1999). Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. American Journal of Psychiatry, 156, 946–948.PubMedGoogle Scholar
  57. Lorenz, R. (2004). On the application of cannabis in paediatrics and epileptology. Neuroendocrinology Letters, 25(1–2), 40–44.PubMedGoogle Scholar
  58. Malhi, G., Chengappa, K., Gershon, S., & Goldberg, J. (2010). Hypomania: Hype or mania? Bipolar Disorders, 12, 758–763.PubMedGoogle Scholar
  59. Manber, R., Schnyer, R., Allen, J., Rush, A. J., & Blasey, C. (2004). Acupuncture: A promising treatment for depression during pregnancy. Journal of Affective Disorders, 83, 89–95.PubMedGoogle Scholar
  60. Martinez, J., Marangell, L., & Hollrah, L. (2005). Vagus nerve stimulation: Current use and potential applications in child and adolescent psychiatry. Child and Adolescent Clinics of North America, 14, 177–191.Google Scholar
  61. Matthews, K., & Eljamel, M. (2003). Vagus nerve stimulation and refractory depression. British Journal of Psychiatry, 183, 181–183.PubMedGoogle Scholar
  62. Maudsley, H. (1869). On opium in the treatment of insanity. The Practitioner, 2, 1–8.Google Scholar
  63. Maxwell, J. (2011). The prescription drug epidemic in the United States. Drug and Alcohol Review, 30, 264–270.PubMedGoogle Scholar
  64. Miller, J., Bilder, D., Farley, M., Coon, H., Pinborough-Zimmerman, J., Jenson, W., et al. (2013). Autism spectrum disorder reclassified. Journal of Autism and Developmental Disorders, 43, 200–210.PubMedGoogle Scholar
  65. Mitchell, S. W. (1904). The evolution of the rest treatment. Journal of Nervous and Mental Disease, 31, 368–373.Google Scholar
  66. Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., et al. (2000). Coverage by the news media of the benefits and risks of medications. New England Journal of Medicine, 324, 1645–1650.Google Scholar
  67. Nahas, Z., Kozel, F. A., Li, X., Anderson, B., & George, M. S. (2003). Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder. Bipolar Disorders, 5(1), 40–47.PubMedGoogle Scholar
  68. Nelson, P., & Erickson, D. (1949). Hydrotherapy for psychiatric patients. Medical Clinics of North America, 33, 97–108.Google Scholar
  69. Newth, A. H. (1884). The value of electricity in the treatment of insanity. Journal of Mental Science, 30, 354–359.Google Scholar
  70. Notkin, J., Greeff, J., Pike, F., & Killian, J. (1933). Changes in the clinical signs and laboratory findings in various types of psychoses under the influence of subcutaneous administration of oxygen. American Journal of Psychiatry, 12, 1275–1305.Google Scholar
  71. Noyes, A. (1951). Modern clinical psychiatry (3rd ed.). Philadelphia: Saunders.Google Scholar
  72. Oliveira, S. (2012). The scope and limits of the medicalization of risk for psychosis. Physis: Journal of Public Health, 22(1), 1–6.Google Scholar
  73. Overholser, J. C. (2002). Treatments for depression: Wisdom imparted from treatments discarded. International Journal of Psychiatry in Medicine, 32(4), 317–336.PubMedGoogle Scholar
  74. Overholser, J. C. (2006). Panacea or placebo: The historical quest for medications to treat depression. Journal of Contemporary Psychotherapy, 36, 183–190.Google Scholar
  75. Overholser, J. C. (2010). Ten criteria to qualify as a scientist-practitioner in clinical psychology. Journal of Contemporary Psychotherapy, 40, 51–59.Google Scholar
  76. Palmer, H., & Braceland, F. (1937). Six years experience with narcosis therapy in psychiatry. American Journal of Psychiatry, 94, 37–57.Google Scholar
  77. Palmer, H., Hastings, D., & Sherman, S. (1941). Therapy in involutional melancholia. American Journal of Psychiatry, 97, 1086–1115.Google Scholar
  78. Palmer, H., & Paine, A. (1932). Prolonged narcosis as therapy in the psychoses. American Journal of Psychiatry, 12, 143–164.Google Scholar
  79. Parfitt, D. (1936). Treatment of psychoses by prolonged narcosis. Lancet, 1, 424–426.Google Scholar
  80. Pflug, B. (1976). The effect of sleep deprivation on depressed patients. Acta Psychiatrica Scandinavica, 53, 148–158.PubMedGoogle Scholar
  81. Pope, H., Cohane, G., Kanayama, G., Siegel, A., & Hudson, J. (2003). Testosterone gel supplementation for men with refractory depression. American Journal of Psychiatry, 160, 105–111.PubMedGoogle Scholar
  82. Posternak, M., Solomon, D., Leon, A., Mueller, T., Shea, T., Endicott, J., et al. (2006). The naturalistic course of unipolar major depression in the absence of somatic therapy. Journal of Nervous and Mental Disease, 194(5), 324–329.PubMedGoogle Scholar
  83. Reynolds, J. (1890). Therapeutical uses and toxic effects of cannabis indica. Lancet, 1, 637–638.Google Scholar
  84. Richardson, A. B. (1891). Simple melancholia and its treatment. Medical News, 58, 685–689.Google Scholar
  85. Robertson, G. (1910). Treatment of mental excitement in asylums. Journal of Mental Science, 56, 700–710.Google Scholar
  86. Rudolf, G. (1931). Experimental treatments of schizophrenia. Journal of Mental Science, 77, 767–791.Google Scholar
  87. Rush, A. J., Marangell, L., Sackheim, H. A., George, M., & Brannan, S. (2005). Vagus nerve stimulation for treatment-resistant depression. Biological Psychiatry, 58(5), 347–354.PubMedGoogle Scholar
  88. Russell, I. (1881). Melancholia. Alienist and Neurologist, 2, 196–207.Google Scholar
  89. Savage, C. (1952). Lysergic acid diethylamide (LSD-25): A clinical-psychological study. American Journal of Psychiatry, 108, 896–900.PubMedGoogle Scholar
  90. Shorter, E. (1992). From paralysis to fatigue: A history of psychosomatic illness in the modern era. New York: Free Press.Google Scholar
  91. Smith, W. (1912). On the use of brain extract in the treatment of various forms of insanity. British Medical Journal, 2, 1451–1454.Google Scholar
  92. Snowden, E. (1927). The psychological treatment of mania and depression. Lancet, 1, 1016–1020.Google Scholar
  93. Stevens, J. (1904). Manic-depressive insanity, with a report of a typical case. Journal of Nervous and Mental Disease, 31, 513–525.Google Scholar
  94. Stockton, G. (1901). Melancholia and its treatment. Philadelphia Medical Journal, 8, 571–573.Google Scholar
  95. Thase, M., & Kupfer, D. (1996). Recent developments in pharmacotherapy of mood disorders. Journal of Consulting and Clinical Psychology, 64, 646–659.PubMedGoogle Scholar
  96. Tuttle, G. (1904). Hydrotherapeutics. American Journal of Insanity, 61, 179–192.Google Scholar
  97. Viner, N. (1933). A case of dementia praecox treated by intraspinal injections of horse serum. Canadian Medical Association Journal, 28(4), 420–422.PubMedCentralPubMedGoogle Scholar
  98. Vovin, R., Aksenova, I., & Sverdlov, L. (1982). Sleep deprivation in the treatment of chronic depressive states. Neuroscience and Behavioral Physiology, 12(2), 92–96.PubMedGoogle Scholar
  99. Walsh, J. (1947). Continuous narcosis. Journal of Mental Science, 93, 255–261.PubMedGoogle Scholar
  100. Wardner, D. (1915). The intra-cranial injection of salvarsanized serum. American Journal of Insanity, 72, 643–648.Google Scholar
  101. Wehr, T., Sack, D., & Rosenthal, N. (1985). Antidepresant effects of sleep deprivation and phototherapy. Acta Psychiatrica Belgica, 85, 593–602.PubMedGoogle Scholar
  102. Wessley, S. (1990). Old wine in new bottles: Neurasthenia and ME. Psychological Medicine, 20, 35–53.Google Scholar
  103. Wiglesworth, J. (1887). On the use of galvanism in the treatment of certain forms of insanity. Journal of Mental Science, 33, 385–395.Google Scholar
  104. Wilsey, O. (1902). Tent life for the insane. American Journal of Insanity, 59, 629–635.Google Scholar
  105. Windholz, G., & Witherspoon, L. (1993). Sleep as a cure for schizophrenia. History of Psychiatry, 4, 83–93.PubMedGoogle Scholar
  106. Witzel, A. (1928). Treatment of the manic-depressive psychoses. Psychiatric Quarterly, 2, 405–421.Google Scholar
  107. Wright, A. (1902). Tent life for the demented and uncleanly. American Journal of Insanity, 59, 315–318.Google Scholar
  108. Zane, T., Davis, C., & Rosswurm, M. (2008). The cost of fad treatments in autism. Journal of Early and Intensive Behavior Intervention, 5(2), 44–51.Google Scholar
  109. Zutshi, A., Eckert, K., Hawthorne, G., Taylor, A., & Goldney, R. (2011). Changes in the prevalence of bipolar disorders between 1998 and 2008 in an Australian population. Bipolar Disorders, 13, 182–188.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PsychologyCase Western Reserve UniversityClevelandUSA

Personalised recommendations